FDA
approval
· 2016-11-25
FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
Summary
The FDA approved a supplemental application for a venlafaxine hydrochloride generic product from BluePoint Laboratories under ANDA077653. This represents a supp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VENLAFAXINE (VENLAFAXINE)